Avi Roy explains why only about 1% to 2% of the semaglutide tablet reaches the blood, while most of a starting Foundayo dose does.
Recap by typeshit. Post by Avi Roy on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Researchers are engineering peptides that hold up in the gut and aim at specific cells, which could let precision medicines be taken by mouth instead of injected.
A short explainer on how the brand Wegovy relates to its active ingredient, semaglutide. Only the question itself is available here.
Loading…